← Open Payments lookup

ERIC RAIMO: Open Payments

NPI 1568429389 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,330 in 54 payments from 12 companies in 2025. Trend: 2023 $892 · 2024 $611 · 2025 $1,330

Food & beverage: $1,330
CompanyPaymentsAmount
Alkermes, Inc.9$314
ABBVIE INC.15$267
Vanda Pharmaceuticals Inc.5$134
E.R. Squibb & Sons, L.L.C.5$112
Otsuka America Pharmaceutical, Inc.5$111
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$82
Neurocrine BioSciences, Inc.3$78
Lundbeck LLC2$68
Axsome Therapeutics, Inc.2$58
Janssen Pharmaceuticals, Inc2$48

Products named: VRAYLAR, ARISTADA, REXULTI, FANAPT, LYBALVI, COBENFY, CAPLYTA, INGREZZA.

Industry payments across CA — which companies pay providers there.